中国私募股权投资：长久机遇
由于周期性和结构性因素，加之地缘政治的影响，中国的投资环境目前正面临着巨大的阻力。尽管面临这些挑战，长期投资者仍然保持乐观。面对低于市值预估的资产，他们兴趣浓厚。这些资产主要集中在技术创新和能源转型领域，是蕴藏于世界第二大经济体的宏观环境中的巨大的机遇。由经验丰富的私募股权投资人组成的专题讨论小组将重点探讨PE投资在中国的发展之路。
- 过去一年，私募市场投资者如何调整在中国的投资策略？中国在全球投资组合中处于什么位置？
- 哪些行业在当下的经济发展中有望继续保持丰厚的利润？
- 目前的（中国资产）估值有多大吸引力，现在是投资的最佳时机吗？
- 中国基金经理如何平衡和重组人民币基金和美元基金？
Confirm cancellation
Something went wrong.
An error occurred trying to play the stream. Please reload the page and try again.
Close
Yiqing Wang is Managing Editor of Mergermarket’s Asia-Pacific M&A and ECM editorial team, which specializes in breaking news on private and public M&A transactions and delivering forward-looking intelligence on corporate strategy. Yiqing spearheads the editorial strategy and oversees day-to-day operations, to deliver timely, actionable insights and analysis to help clients make better deal-making and investment decisions. Additionally, she frequently moderates panels and chairs conferences at ION Analytics events, bringing industry insights to the forefront.
She has been an investigative M&A reporter and editor since 2009, writing news ranging from healthcare, renewable energy and financial service, etc.
Yiqing achieved her master's degree of multilingual multicultural studies from New York University.
陈中崛先生是贝恩投资私募股权的合伙人，也是亚太私募股权团队的创始成员之一，常驻香港。陈先生于2005年加入贝恩资本，曾分别在波士顿和香港办事处工作，持续专注于科技、工业、金融和商业服务领域的成长资本和收购。在加入贝恩资本私募股权之前，陈先生在贝恩咨询波士顿办公室任职咨询顾问。早年他还在中国投资有限责任公司任职。
陈先生于哈佛大学商学院获得MBA学位，并以全优的成绩毕业于哈佛大学，获得经济学学士学位。
Charles joined CDH in 2018 and leads an investment team focused on Advanced Manufacturing & Technology. He is now a member of investment committee of CDH Private Equity. Prior to joining CDH, Charles was a Founding Partner with KYI Capital , a private equity firm focusing on core technology investments, and a Managing Partner with Beijing Semi Fund, a private equity firm focusing on semiconductor investments. Prior to that, Charles was a Director with CVCi and a Senior Engagement Manager with McKinsey & Company. He received his M.B.A. from IMD Business School in Switzerland and his B.E. in Electrical Engineering & Computer Science from Shanghai Jiaotong University.
黃德炜先生为太盟投资集团合伙人、私市股权联席主管，负责统领私市股权策略部门的运营及管理。黄先生自2011年3月起加入太盟投资集团担任执行董事，自2014年4月起一直担任集团合伙人。黄先生是太盟投资集团管理委员会成员。
黄德炜先生有25年的金融行业从业经验。加入太盟投资集团之前，黄先生于2006年至2010年曾任职于美国另类资产管理公司TPG，担任副总裁职务并负责亚洲地区股权投资的评估和执行。此前，他于1999年至2005年曾任职于摩根士丹利投资银行部，先后从事中国市场的并购和股权融资业务以及北美中型企业并购业务工作。
黄先生于1999年5月获得加州大学伯克利分校工商管理和亚洲研究学士学位。
Rebecca Xu is a Co-Founder and Managing Director of Asia Alternatives. Ms. Xu splits her time between Asia Alternatives’ Beijing, Shanghai and Hong Kong offices. Ms. Xu is on the Firm’s Investment Committee and co-leads Asia Alternatives’ investments in growth and venture capital funds, focusing most of her time on Asia Alternatives’ China investments.
Prior to starting Asia Alternatives, Ms. Xu was a Senior Investment Officer at the Funds Group of the International Finance Corporation (“IFC”), the private sector investment arm of the World Bank Group. There, she had the primary responsibility of leading IFC’s fund investing and portfolio supervision in Asia for over six years. Previously, Ms. Xu also worked at McKinsey & Co, Inc. (Washington D.C.) and HSBC (Hong Kong).
Ms. Xu received an M.B.A. from Harvard Business School and holds a Bachelor’s degree in International Relations from the Foreign Affairs College in Beijing, China. Ms. Xu is fluent in Mandarin Chinese.
Ms. Xu currently serves on the Advisory Boards for a number of Asia Alternatives’ China and India private equity funds. In addition, she serves as the Chairwoman of the Hong Kong Venture Capital and Private Equity Association (HKVCA) and on the Board of the Chun Hui Bo’ai Children’s Foundation.
郑力元先生于 2020 年 1 月加入 Investcorp，现任新兴市场联合负责人，负责海合会国家、东南亚和大中华区业务。他在任职期间的知名投资项目包括谷物食品品牌 VizBrands、陆道培血液肿瘤医疗集团、牙科 SaaS 服务商领健、高端制造商嘉诺等。
此前，郑力元先生在德国法兰克福知名私募股权公司Triton担任负责人， 早期曾在美国达拉斯投资机构Hicks Muse Tate & Furst任职，该机构旨在在欧洲和北美主导商业服务、工业和消费领域的控股权收购交易。郑力元先生的职业生涯始于纽约投行所罗门兄弟，他拥有波士顿学院管理和金融科学学士学位，以及清华大学五道口金融学院授予的产业与金融高管学位证书。